GLP1R and obesity due to melanocortin 4 receptor deficiency: Compared with HRQOL reported in clinical trials of the glucagon-like peptide 1 receptor agonist semaglutide in patients with general obesity, patients with BBS reported comparable or worse baseline HRQOL than those with general obesity [42].